Osaic Holdings
VKTX icon

Osaic Holdings’s Viking Therapeutics VKTX Stock Holding History

Osaic Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Sell
70,805
-6,182
-8% -$200K ﹤0.01% 2037
2026
Q1 		$2.51M Buy
76,987
+17,213
+29% +$553K ﹤0.01% 1895
2025
Q4 		$2.1M Sell
59,774
-18,848
-24% -$668K ﹤0.01% 2047
2025
Q3 		$2.11M Buy
78,622
+2,970
+4% +$88.6K ﹤0.01% 2131
2025
Q2 		$2M Sell
75,652
-4,407
-6% -$116K ﹤0.01% 1902
2025
Q1 		$1.93M Buy
80,059
+24,775
+45% +$783K ﹤0.01% 1704
2024
Q4 		$2.22M Buy
55,284
+19,091
+53% +$1.09M 0.01% 1572
2024
Q3 		$2.29M Buy
36,193
+8,002
+28% +$469K 0.01% 1592
2024
Q2 		$1.49M Sell
28,191
-2,735
-9% -$179K ﹤0.01% 1848
2024
Q1 		$2.54M Buy
30,926
+1,040
+3% +$46.3K 0.01% 1520
2023
Q4 		$556K Sell
29,886
-193,409
-87% -$2.53M ﹤0.01% 3071
2023
Q3 		$2.47M Buy
223,295
+114,863
+106% +$1.64M ﹤0.01% 1802
2023
Q2 		$1.76M Sell
108,432
-18,939
-15% -$397K ﹤0.01% 1989
2023
Q1 		$2.12M Sell
127,371
-20,533
-14% -$212K ﹤0.01% 1785
2022
Q4 		$1.39M Buy
147,904
+1,466
+1% +$6.54K ﹤0.01% 2052
2022
Q3 		$399K Buy
146,438
+5,187
+4% +$17K ﹤0.01% 3109
2022
Q2 		$408K Buy
141,251
+31,887
+29% +$78.9K ﹤0.01% 3135
2022
Q1 		$929K Buy
109,364
+20,228
+23% +$72.6K ﹤0.01% 2645
2021
Q4 		$410K Buy
89,136
+9,171
+11% +$51.4K ﹤0.01% 3255
2021
Q3 		$502K Buy
79,965
+2,200
+3% +$13.6K ﹤0.01% 3025
2021
Q2 		$466K Buy
77,765
+5,320
+7% +$31.6K ﹤0.01% 3106
2021
Q1 		$458K Sell
72,445
-2,770
-4% -$19.5K ﹤0.01% 2957
2020
Q4 		$423K Buy
75,215
+2,930
+4% +$17.7K ﹤0.01% 2810
2020
Q3 		$422K Buy
72,285
+11,387
+19% +$78.4K ﹤0.01% 2585
2020
Q2 		$439K Buy
60,898
+17,077
+39% +$113K ﹤0.01% 2461
2020
Q1 		$204K Buy
+43,821
New +$269K ﹤0.01% 2851

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Osaic Holdings's VKTX Position: Q2 2026 in Review

Osaic Holdings reduced its Viking Therapeutics (VKTX) stake by 8% in Q2 2026, selling an estimated $200K and leaving 70,805 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

Osaic Holdings first reported a position in VKTX in Q1 2020 and has held it in 26 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Osaic Holdings held 70,805 shares of Viking Therapeutics worth $2.76M as of Q2 2026.
  • Osaic Holdings sold 6,182 Viking Therapeutics shares in Q2 2026, an estimated $200K.
  • Viking Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2037 holding.
  • Osaic Holdings first reported a position in Viking Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.